TESK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.384160E-01
Normal-vs-Stage2
3.579600E-01
Normal-vs-Stage3
2.445600E-01
Normal-vs-Stage4
3.877800E-01
Stage1-vs-Stage2
6.116400E-01
Stage1-vs-Stage3
3.884600E-01
Stage1-vs-Stage4
4.293400E-01
Stage2-vs-Stage3
9.979700E-02
Stage2-vs-Stage4
3.181600E-01
Stage3-vs-Stage4
1.218760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.517000E-01
Normal-vs-AfricanAmerican
3.932400E-01
Normal-vs-Asian
3.009400E-01
Caucasian-vs-AfricanAmerican
6.840400E-01
Caucasian-vs-Asian
2.725400E-01
AfricanAmerican-vs-Asian
3.145800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.435000E-01
Normal-vs-Female
3.564800E-01
Male-vs-Female
6.220200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.695200E-01
Normal-vs-Age(41-60Yrs)
4.060800E-01
Normal-vs-Age(61-80Yrs)
3.270400E-01
Normal-vs-Age(81-100Yrs)
3.271400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.671800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.433800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.855600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.521700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.586440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.498000E-01
Normal-vs-Daily Drinker
3.453400E-01
Normal-vs-Weekly Drinker
2.994200E-01
Normal-vs-Occasional Drinker
3.515200E-01
Normal-vs-Social Drinker
4.233600E-01
Non Drinker-vs-Daily Drinker
9.505600E-01
Non Drinker-vs-Weekly Drinker
4.390800E-01
Non Drinker-vs-Occasional Drinker
9.512600E-01
Non Drinker-vs-Social Drinker
3.574400E-01
Daily Drinker-vs-Weekly Drinker
4.049400E-01
Daily Drinker-vs-Occasional Drinker
8.935200E-01
Daily Drinker-vs-Social Drinker
2.746400E-01
Weekly Drinker-vs-Occasional Drinker
2.723600E-01
Weekly Drinker-vs-Social Drinker
6.522000E-02
Occasional Drinker-vs-Social Drinker
2.776000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.310200E-01
Normal-vs-Grade 2
6.658800E-01
Normal-vs-Grade 3
9.220800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.778300E-02
Grade 1-vs-Grade 3
2.326400E-01
Grade 1-vs-Grade 4
9.310200E-01
Grade 2-vs-Grade 3
2.950800E-01
Grade 2-vs-Grade 4
6.658800E-01
Grade 3-vs-Grade 4
9.220800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.720800E-01
Normal-vs-NonDiabetic
3.306800E-01
Diabetic-vs-NonDiabetic
3.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.619400E-01
Normal-vs-NoPancreatitis
3.423000E-01
Pancreatitis-vs-NoPancreatitis
7.686000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.483600E-01
Normal-vs-N1
3.558200E-01
N0-vs-N1
7.960000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.244000E-01
Normal-vs-TP53-NonMutant
3.648000E-01
TP53-Mutant-vs-TP53-NonMutant
3.157000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
